A recent analysis of cDC1-deficient mice revealed that cDC1 acts as a distinctive subset capable of cross-presenting tumor Ags to naïve CD8+ T cells in TdLNs, resulting in the generation of tumor-specific CTLs for the elimination of tumor (4–6, 8–10). The gene discussed is CD8A; the disease is neoplasm.